Share on LinkedInShare on LinkedIn

ARTICLE · 14 SEPTEMBER 2016

Magistrate Judge Nixes TB Test Kit Claims

U.S. Magistrate Judge Cabell of the U.S. District Court for the District of Massachusetts determined that TB test kit claims do not satisfy the patent eligibility requirement of 35 USC § 101.

United StatesIntellectual Property

In a "Report and Recommendation on Defendants' Joint Motion To Dismiss," U.S. Magistrate Judge Cabell of the U.S. District Court for the District of Massachusetts determined that TB test kit claims do not satisfy the patent eligibility requirement of 35 USC § 101, but declined to reach the same conclusion with regard to related method claims. The decision was issued in Oxford Immunotec Ltd. v. Qiagen, Inc., where Oxford has asserted that Qiagen's test kits for diagnosing TB infection in vitro infringe a number of its patents.

The TB Test Kit Claims At Issue

Three TB test kit claims from three different patents were at issue:

Claim 7 of U.S. Patent 7,632,646  (issued December 15, 2009):

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from